Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Solazyme, Inc. Business Wire SAN DIEGO -- June 24, 2013 Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Solazyme, Inc. (Nasdaq:SZYM) violated state or federal laws when communicating to shareholders about the Solazyme Roquette Nutritionals joint venture. According to Johnson & Weaver, LLP, shares of Solazyme have declined more than 10% in early morning trading since the announcement made on June 24, 2013 that it has agreed with Roquette Frères, S.A. to dissolve their joint venture, Solazyme Roquette Nutritionals, LLC. Johnson & Weaver’s investigation is ongoing and addresses the timeline of possible misleading statements specifically regarding the outlook of the joint venture with Roquette Frères. Jim Baker, Lead Analyst for Johnson & Weaver, stated that, “It appears that the project has been in jeopardy for some time despite statements made by senior management to the contrary.” Baker continued, “Additionally, management has been aggressively selling their shares in recent months.” If you have information that could assist in this investigation, or if you are a Solazyme shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (email@example.com)by email or by phone at 619-230-0063 Ext. 118. Johnson & Weaver, LLP is a nationally recognized shareholders’ rights law firm. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visithttp://www.johnsonandweaver.com. Contact: Johnson & Weaver, LLP 619-230-0063 Jim Baker, Ext. 118 firstname.lastname@example.org
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Solazyme, Inc.
Press spacebar to pause and continue. Press esc to stop.